Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 2
2011 1
2012 2
2013 10
2014 11
2015 3
2017 2
2018 3
2020 4
2021 3
2022 4
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
In Vitro Simulation of the Fasted Gastric Conditions and Their Variability to Elucidate Contrasting Properties of the Marketed Dabigatran Etexilate Pellet-Filled Capsules and Loose Pellets.
Staniszewska M, Myslitska D, Romański M, Polak S, Garbacz G, Dobosz J, Smoleński M, Paszkowska J, Danielak D. Staniszewska M, et al. Among authors: garbacz g. Mol Pharm. 2024 Apr 3. doi: 10.1021/acs.molpharmaceut.4c00025. Online ahead of print. Mol Pharm. 2024. PMID: 38568423
An extension of biorelevant fed-state dissolution tests to clinical pharmacokinetics - A study on gastrointestinal factors influencing rivaroxaban exposure and efficacy in atrial fibrillation patients.
Romański M, Giebułtowicz J, Gniazdowska E, Piotrowski R, Żuk A, Kułakowski P, Paszkowska J, Myslitska D, Sczodrok J, Garbacz G, Danielak D. Romański M, et al. Among authors: garbacz g. Int J Pharm. 2024 Jan 5;649:123626. doi: 10.1016/j.ijpharm.2023.123626. Epub 2023 Nov 23. Int J Pharm. 2024. PMID: 38000647
A Rational Approach to Predicting Immediate Release Formulation Behavior in Multiple Gastric Motility Patterns: A Combination of a Biorelevant Apparatus, Design of Experiments, and Machine Learning.
Staniszewska M, Romański M, Polak S, Garbacz G, Dobosz J, Myslitska D, Romanova S, Paszkowska J, Danielak D. Staniszewska M, et al. Among authors: garbacz g. Pharmaceutics. 2023 Jul 31;15(8):2056. doi: 10.3390/pharmaceutics15082056. Pharmaceutics. 2023. PMID: 37631270 Free PMC article.
Application of a novel PhysioCell apparatus for biopredictive dissolution tests of oral immediate release formulations - A case study workflow for in vitro-in vivo predictions.
Romański M, Staniszewska M, Paszkowska J, Dobosz J, Romanova S, Pieczuro J, Kątny M, Roznerska D, Szczepański J, Schraube M, Renn-Hojan M, Puk E, Hrem O, Garbacz G, Danielak D. Romański M, et al. Among authors: garbacz g. Int J Pharm. 2023 Jun 25;641:123061. doi: 10.1016/j.ijpharm.2023.123061. Epub 2023 May 19. Int J Pharm. 2023. PMID: 37211237
Conjunction of semi-mechanistic in vitro-in vivo modeling and population pharmacokinetics as a tool for virtual bioequivalence analysis - a case study for a BCS class II drug.
Danielak D, Paszkowska J, Staniszewska M, Garbacz G, Terlecka A, Kubiak B, Romański M. Danielak D, et al. Among authors: garbacz g. Eur J Pharm Biopharm. 2023 May;186:132-143. doi: 10.1016/j.ejpb.2023.03.014. Epub 2023 Apr 2. Eur J Pharm Biopharm. 2023. PMID: 37015321 Free article.
Dissolution of a Biopharmaceutics Classification System Class II Free Acid from Immediate Release Tablets Containing a Microenvironmental pH Modulator: Comparison of a Biorelevant Bicarbonate Buffering System with Phosphate Buffers.
Haznar-Garbacz D, Hoc D, Garbacz G, Lachman M, Słomińska D, Romański M. Haznar-Garbacz D, et al. Among authors: garbacz g. AAPS PharmSciTech. 2022 Jul 26;23(6):203. doi: 10.1208/s12249-022-02310-z. AAPS PharmSciTech. 2022. PMID: 35882674
46 results